Diabetes Clinical Trials in North Carolina

Showing 241-260 of 292 trials

A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione

NCT00743002

This trial is designed to show the effect of treatment with TT223 or placebo on blood glucose control after 12 weeks of treatment with a 6 month follow-up. TT223 is administered by injection once daily to patients currently treated with Metformin and/or Thiazolidinedione.

Diabetes Mellitus, Type 2

OPKO Health, Inc.87 participantsStarted Aug 2008

Artesia, California, United States • Los Angeles, California, United States • Santa Ana, California, United States +17 more locations

COMPLETED5.4 miles

Follow-Up Study for Exubera

NCT00734591

In studies of Exubera in persons with diabetes, lung cancer occurred in a few more people who were taking Exubera than in people who were taking other diabetes medicines. All subjects diagnosed with lung cancer had a history of smoking and the number of lung cancer cases observed fell within the expected range based on population-based data. There is currently not enough information to determine if any of the observed lung cancer cases were related to Exubera use, therefore, the study is being conducted to further investigate whether Exubera use makes the appearance of lung cancer more likely.

Diabetes Mellitus

Pfizer7,439 participantsStarted Aug 2008

Bay Minette, Alabama, United States • Graysville, Alabama, United States • Pell City, Alabama, United States +318 more locations

A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione

Follow-Up Study for Exubera

Diabetes Trials in Other Cities

A Randomized, Double-Blind, Comparator- and Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602 in Type 2 Diabetic Patients

Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone

Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus

Efficacy and Safety of B I1356 (Linagliptin) vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 Diabetes

Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes

Markers and Mechanisms of Vascular Disease in Type II Diabetes

Dapagliflozin DPPIV Inhibitor add-on Study

Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on Hemodialysis

Screening for Early Evidence of Diabetes

Impact of a Diabetes Risk Score on Lifestyle Education and Patient Adherence

Study of Insulin Lispro in Participants With Inadequately Controlled Type 2 Diabetes

Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes

Exploratory Study to Access the Metabolic Effects of Ranolazine in Subjects With Type 2 Diabetes Mellitus When Added to Ongoing Non-insulin Antidiabetic Therapy

A 6 Week Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of GK1-399 in Type 2 Diabetes

Diabetes and Periodontal Therapy Trial

A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of CNTO 3649 in Healthy Adults and Patients With Type 2 Diabetes Mellitus

Mechanisms of Glucose Lowering Effect of Colesevelam HCl

Other Conditions in North Carolina